FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

385233001: Infusion concentrate (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1459412015 Infusion concentrate (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    1479490013 Infusion concentrate en Synonym Active Entire term case insensitive SNOMED CT core module
    2660206012 Infusion concentrate (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Infusion concentrate Is a Type of drug preparation false Inferred relationship Existential restriction modifier
    Infusion concentrate Is a Parenteral dose form false Inferred relationship Existential restriction modifier
    Infusion concentrate Has dose form intended site Parenteral false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Cisplatin 1mg/mL infusion concentrate 10mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Tacrolimus 5mg/mL infusion concentrate 1mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Norepinephrine acid tartrate 2mg/mL infusion concentrate 2mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Cisplatin 1mg/mL infusion concentrate 100mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Norepinephrine acid tartrate 2mg/mL infusion concentrate 4mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Cisplatin 1mg/mL infusion concentrate 50mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Cisplatin 500micrograms/mL infusion concentrate 20mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Norepinephrine acid tartrate 2mg/mL infusion concentrate 20mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Isoproterenol hydrochloride 2mg/2mL infusion concentrate Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Atosiban 7.5mg/mL infusion concentrate 5mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 10mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Amsacrine 5mg/mL infusion concentrate 15mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Alprostadil 500micrograms/mL infusion concentrate 1mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Dopexamine hydrochloride 10mg/mL infusion concentrate 5mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Amphotericin 5mg/mL infusion concentrate 20mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Dopamine hydrochloride 40mg/mL infusion concentrate 5mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Cardioplegia infusion concentrate vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Co-trimoxazole 16mg/80mg/mL infusion concentrate 5mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Dopamine hydrochloride 160mg/mL infusion concentrate 5mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Dinoprostone 10mg/mL injection concentrate 0.5mL ampule with diluent Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Etoposide 20mg infusion concentrate 10mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Rituximab 10mg/mL infusion concentrate 50mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Dobutamine 12.5mg/mL infusion concentrate 20mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Dinoprostone 1mg/mL infusion concentrate 0.75mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Sodium nitroprusside 10mg/mL infusion concentrate 5mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Dobutamine 50mg/mL infusion concentrate 5mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Etoposide 1g infusion concentrate vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Etoposide 100mg infusion concentrate vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Cladribine 1mg/mL infusion concentrate 10mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Etoposide 500mg infusion concentrate vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Itraconazole 10mg/mL infusion concentrate 25mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Docetaxel 40mg/mL infusion concentrate 2mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Dinoprostone 10mg/mL infusion concentrate 0.5mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Sodium clodronate 60mg/mL infusion concentrate 5mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Etoposide 150mg infusion concentrate vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Cidofovir 75mg/mL infusion concentrate 5mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Etoposide 20mg infusion concentrate 25mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Docetaxel 40mg/mL infusion concentrate 0.5mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Alemtuzumab 30mg/mL infusion concentrate Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Amiodarone hydrochloride 50mg/mL infusion concentrate 3mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Tirofiban hydrochloride 0.05mg infusion concentrate 500mL bottle Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Phenoxybenzamine hydrochloride 50mg/mL infusion concentrate 2mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Mitozantrone 2mg/mL infusion concentrate 10mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Tirofiban 250micrograms/mL infusion concentrate 50mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Pamidronate disodium 3mg/mL infusion concentrate 5mL vial Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Iloprost 100micrograms/mL infusion concentrate 1mL ampule Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Ipilimumab 5mg/mL solution for intravenous infusion Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (medac UK) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (medac UK) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Hospira UK Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Disodium pamidronate 15mg/5ml solution for infusion vials (A A H Pharmaceuticals Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Dopamine 800mg/5ml solution for infusion ampoules (Goldshield Pharmaceuticals Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vial (Accord Healthcare Ltd) (product) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vial (Accord Healthcare Ltd) (product) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Amiodarone 150mg/3ml concentrate for solution for injection ampoules (hameln pharma Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Sun Pharmaceuticals UK Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Atosiban 37.5mg/5ml solution for infusion vials (A A H Pharmaceuticals Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Noradrenaline (Norepinephrine) 2mg/2ml concentrate for solution for Infusion ampoules (Wockhardt UK Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Truxima 500mg/50ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Rixathon 500mg/50ml concentrate for solution for infusion vials (Sandoz Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Amiodarone 150mg/3ml concentrate for solution for injection ampoules (Bowmed Ibisqus Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Bowmed Ibisqus Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has manufactured dose form False Infusion concentrate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start